Cheap Indian Drugs Spur Rare Congressional Bipartisanship

It looks as if we have a sighting of that rare Washington, D.C., unicorn: bipartisan agreement in the halls of Congress. Democrats and Republicans have united in defense of Big Pharma and are lobbying the Obama administration and State Department to pressure India's generic-drug policies.

In this video, health-care analyst David Williamson discusses what has Congress riled up, the importance of India as a growth driver for the pharma industry, and whether investors need to start taking precautions with their portfolios.

Rising health-care costs continue to be a hotly debated topic, and even legendary investor Warren Buffett called this trend "the tapeworm that's eating at American competitiveness." To learn more about what's happening to the health care system -- and how to potentially profit from this trend -- click here for free, immediate access.

Follow David on Twitter: @MotleyDavid.

Read/Post Comments (1) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On July 01, 2013, at 3:32 PM, rmm200 wrote:

    Any time the Republicans and Democrats come together, it is a sure bet that we, the American voters, are the losers.

    Indian pharmaceutical companies are one on the few bright spots on the healthcare horizon.

    Ask yourselves why Americans pay more for prescription drugs than our neighbors in Canada or Europe. You have the US Congress to thank for that.

    Vote them out - they deserve it.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2517078, ~/Articles/ArticleHandler.aspx, 9/29/2016 11:54:45 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,301.13 -38.11 -0.21%
S&P 500 2,167.57 -3.80 -0.18%
NASD 5,295.15 -23.40 -0.44%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/29/2016 11:39 AM
AGN $233.00 Down -4.79 -2.01%
Allergan CAPS Rating: ****
NVS $80.06 Down -1.16 -1.43%
Novartis CAPS Rating: ****
PFE $33.78 Down -0.21 -0.62%
Pfizer CAPS Rating: ****
RDY $46.54 Down -1.35 -2.82%
Dr. Reddy's Labora… CAPS Rating: ****